IA
ANGO icon

IndexIQ Advisors’s AngioDynamics ANGO Stock Holding History

IndexIQ Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-18,047
Closed -$498K – 1317
2021
Q4 		$498K Sell
18,047
-1,167
-6% -$32.2K 0.02% 571
2021
Q3 		$498K Buy
19,214
+1,925
+11% +$51.5K 0.02% 554
2021
Q2 		$469K Sell
17,289
-573
-3% -$14K 0.02% 506
2021
Q1 		$418K Sell
17,862
-2,219
-11% -$44.9K 0.01% 462
2020
Q4 		$308K Buy
20,081
+2,073
+12% +$26.3K 0.01% 654
2020
Q3 		$217K Buy
18,008
+978
+6% +$9.28K 0.01% 574
2020
Q2 		$173K Sell
17,030
-1,603
-9% -$16.5K 0.01% 716
2020
Q1 		$194K Buy
+18,633
New +$234K 0.01% 346

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

IndexIQ Advisors's ANGO Position: Q1 2022 in Review

IndexIQ Advisors sold out of AngioDynamics (ANGO) in Q1 2022, closing a stake of 18,047 shares — an estimated $498K sold.

IndexIQ Advisors first reported a position in ANGO in Q1 2020 and held it in 8 quarters. The position peaked at $498K in Q4 2021. 144 funds tracked by Wall St. Rank hold ANGO as of Q1 2022.

  • IndexIQ Advisors reported no remaining AngioDynamics position as of Q1 2022 after selling out during the quarter.
  • IndexIQ Advisors sold 18,047 AngioDynamics shares in Q1 2022, an estimated $498K.
  • IndexIQ Advisors first reported a position in AngioDynamics in Q1 2020 and held it in 8 quarters.
  • IndexIQ Advisors's AngioDynamics position peaked at $498K in Q4 2021.
  • 144 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.